UPDATED MEDICINES FOR DIABETICS
Main Article Content
Keywords
diabetes, updated medicines, blood sugar control, medication, management
Abstract
Diabetes is a chronic condition that affects millions of people worldwide. Management of diabetes primarily involves lifestyle modifications, including diet and exercise, as well as medication. Over the years, there have been significant advancements in the field of diabetes management, especially in the development of new and updated medicines for diabetics. These updated medicines offer better control of blood sugar levels, reduced side effects, and improved overall quality of life for individuals living with diabetes. This essay explores the latest medications available for diabetics, highlighting their mechanisms of action, benefits, and potential side effects.
References
2. Buse, J. B., Wexler, D. J., Tsapas, A., Rossing, P., Mingrone, G., Mathieu, C., ... & Avogaro, A. (2020). 2. 2019 update to: Management of hyperglycemia in type 2 diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care, 43(2), 487-493.
3. Davies, M. J., D'Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., ... & Siegel, A. J. (2018). 2. Management of hyperglycemia in type 2 diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care, 41(12), 2669-2701.
4. Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., ... & Garber, J. (2019). 2. Consensus statement by the American Association of Clinical Endocrinology and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm—2019 executive summary. Endocrine Practice, 25(1), 69-100.
5. Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., ... & Matthews, D. R. (2012). Management of Hyperglycemia in Type 2 Diabetes, 2015: A patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 38(1), 140-149.
6. Jabbour, S. A., & Frías, J. P. (2017). Review of the safety and efficacy of dapagliflozin in patients with type 2 diabetes. Therapeutic advances in drug safety, 8(6), 237-245.
7. Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F., Nauck, M. A., ... & Poulter, N. R. (2016). Liraglutide and cardiovascular outcomes in type 2 diabetes. New England Journal of Medicine, 375(4), 311-322.
8. Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., ... & Matthews, D. R. (2017). Canagliflozin and cardiovascular and renal events in type 2 diabetes. New England Journal of Medicine, 377(7), 644-657.
9. Pratley, R. E., Nauck, M., Bailey, T., Montanya, E., Cuddihy, R., Filetti, S., ... & Raz, I. (2014). Liraglutide versus sitagliptin for the treatment of patients with type 2 diabetes: a 26-week, randomized, controlled, open-label trial (LEAD-3). Diabetes Care, 37(8), 2022-2030.
10. Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., ... & Inzucchi, S. E. (2015). Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. New England Journal of Medicine, 373(22), 2117-2128.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Mohammed Dakhilallah Alnefaie
Pharmacy technician,East Jeddah Hospital
Rasheed Hussain alotaibi
Pharmacy Technician, Jeddah Health Compliance Department
Saleem Mohammed Alotaibi
Pharmacy technician, Health monitoring centers in Jeddah Islamic Port
Naif Abdullah Alnafeiai
Pharmacy technician, King Fahd Hospital
Mutaz Abdullah Alotaibi
Pharmacy Technician, Jeddah Health Compliance Department, Al-Thagher General Hospital
Mubarak Turky Alotaibi
Pharmacy technician, The first cluster in Jeddah Health, Al-Thagher General Hospital
Sultan Ali Alamri
Pharmacist, King Fahad General Hospital-Jeddah